巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Ampio Pharmaceuticals

    AMPE
    0.107
    0.000
    0.00%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Ampio Pharmaceuticals - 延遲價格・最後更新於 15/08 22:00
    最高位
    --
    最低位
    --
    開市價
    --
    前收市價
    0.107
    成交量(千)
    --
    成交額(百萬)
    --
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    24.14
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    1.830 - 0.093
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Ampio Pharmaceuticals
    證券代碼
    AMPE.US
    所屬板塊
    Biotechnology
    公司業務
    Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.
    發行量
    226286867
    公司總部
    373 Inverness Parkway, Suite 200
    公司網址
    https://www.ampiopharma.com
    公司電郵
    info@ampiopharma.com
    公司電話
    +1 720 437-6500
    暫無內容

    關於

    Ampio Pharmaceuticals(AMPE.US)所屬的行業板塊為Biotechnology。
    Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.
    詳細公司背景可參考: https://www.ampiopharma.com